Loading...
NPI 1033383351 · Fort Myers, FL · Anatomic Pathology & Clinical Pathology Physician
Customize your policy alerts
Get alerted when relevant policies change without checking for updates manually.
Monitor payer policy activity
Ryan Olson is a anatomic pathology & clinical pathology physician provider located in Fort Myers, Florida. This profile covers 110 Medicare and 1 Medicaid CPT/HCPCS procedure codes, with claims volume, average reimbursement, and total revenue by code, benchmarked against other providers billing the same services.
Provider details (source: NPPES NPI Registry)
| Field | Value |
|---|---|
| Entity Type | Individual |
| Organization | Ryan Olson |
| Address | 3840 Broadway |
| City | Fort Myers |
| State | FL |
| ZIP | 33901 |
| Taxonomy | Anatomic Pathology & Clinical Pathology Physician |
| NPI Enumerated | April 17, 2008 |
Lifetime revenue by payer source (source: CMS Medicare & Medicaid claims data)
| Payer Source | Total Paid |
|---|---|
| Medicare | $12.8M |
| Medicaid | $80 |
This provider operates as a high-volume anatomic and clinical pathology laboratory with a mix of advanced molecular oncology testing and very large-scale routine chemistry/immunology throughput. The top Medicare revenue drivers include 81455 ($2.5M, 22.1% of Medicare revenue), 80053 ($1.8M, 15.8%), and 82728 ($737.3K, 6.6%), and the precomputed top-three Medicare codes account for 44.5% of this provider's total Medicare revenue — a profile consistent with a lab that supports both specialized tumor testing and mass clinical testing workflows.
Revenue concentration is pronounced and payer-specific: Medicare dominates with $12.8M in lifetime revenue while Medicaid is de minimis at $77 total. Reported Medicaid activity is concentrated in a single procedure entry, 80053 (63 revenue), which the precomputed table lists as accounting for 100.0% of the provider’s Medicaid revenue, indicating virtually no Medicaid footprint relative to Medicare.
The payer mix is effectively single-payer in scale: $12.8M from Medicare versus $77 from Medicaid shows Medicare is the commercial operating base for this NPI. Analysts should treat this entity as Medicare-centric for network capacity, utilization, and risk-adjustment considerations rather than as a dual-payer practice.
Competitive standing varies by service line: for routine and many immunochemistry/hematology assays the provider is a national high-volume outlier (for example, 80053 ranks #30 of 26416, 100th percentile; 82728 ranks #8 of 8797, 100th percentile; 86334 ranks #6 of 1806, 100th percentile). By contrast, the high-revenue genomic panel 81455 ($2.5M) ranks #6 of 36 nationally (86th percentile) and is characterized in the data as a typical, unremarkable volume for that specific code pool, suggesting strong dominance in routine testing but more middling relative presence in the smaller molecular-panel market.
Service-line signals point to a strong oncology and hematopathology diagnostic footprint: high-revenue molecular and tissue-based codes such as 81455 ($2.5M), 88374 ($360.7K), 86334 ($393.9K), and tumor-marker testing like 86300 ($334.9K) indicate substantial cancer-related diagnostic activity and slide-based pathology interpretation. The mix of these codes alongside high volumes of immunofixation and flow cytometry suggests the lab provides integrated molecular, IHC/ISH, and hematologic diagnostic services to support oncology care pathways.
The provider shows exceptional throughput on many routine analytes and immunology tests, routinely flagged as statistical high-volume outliers: examples include 82784 ($508.2K, 99th percentile; extreme outlier), 83521 ($442.1K, 99th percentile; extreme outlier), 82607 ($430.6K, 100th percentile; extreme outlier), and 83540 ($306.3K, 100th percentile; extreme outlier). These patterns imply large automated chemistry and immunoassay platforms and a referral or centralized testing role for routine and specialty laboratory work.
Claim-count and scale indicators reinforce an institutional lab profile: very large claim volumes such as 80053 with 175.8K claims, 82728 with 56.7K claims, and 82784 with 56.5K claims underscore centralized high-throughput processing rather than small-scale physician office testing. Paired with high per-claim payments on specialty pathology codes (for example, 81455 average paid/claim $2858 and 88374 average paid/claim $158), the financial profile reflects mixed revenue streams from both high-volume low-dollar chemistry and lower-volume high-dollar specialty tests.
The provider has an established tenure in the Medicare program, with NPI enumeration on 2008-04-17 (~18 years ago), which supports interpreting these volume patterns as sustained operational behavior rather than a short-term spike. For contracting, audit planning, or competitive benchmarking, analysts should prioritize Medicare-focused utilization trends given the long-standing Medicare footprint and near-absence of Medicaid revenue.
Medicare revenue breakdown by CPT/HCPCS procedure code.
View: Bar Chart1 / 2
The CPT/HCPCS codes generating the most Medicare revenue for this provider.
110 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 81455 | The lab analyst performs a genomic sequence analysis panel to evaluate the patient specimen, such as tumor tissue or bone marrow, for DNA and possibly RNA alterations in 51 or more genes known to… | 860 | $2,860 | $2.5M |
| 80053 | The lab analyst performs a comprehensive metabolic panel, or CMP test in which he measures the blood level of 14 chemicals the code descriptor lists for the panel. | 175,830 | $10 | $1.8M |
| 82728 | The lab analyst measures the level of ferritin, an important protein composed of about 20 percent iron. Ferritin also acts as an iron reserve in the body, and is present in serum in only minute… | 56,720 | $10 | $737.3K |
| 82784 | The lab analyst performs the technical lab test to analyze the concentration of a particular gamma globulin in the specimen. The analyst may test for immunoglobulin A, immunoglobulin D,… | 56,470 | $10 | $508.2K |
| 83521 | The lab analyst performs a chemistry test to measure the level of each immunoglobulin light chain, kappa or lambda, in a serum specimen. A common lab method for this test is turbidimetry, which uses… | 26,010 | $20 | $442.1K |
| 82607 | The lab analyst performs a test to measure the amount of vitamin B12 in a patient specimen, typically in patient blood. | 28,710 | $20 | $430.6K |
| 88185 | The lab analyst performs the technical component of a flow cytometry procedure using cell surface, cytoplasmic, or nuclear markers to characterize cells and aid clinicians in diagnosing patients with… | 22,490 | $20 | $427.3K |
| 86334 | The lab analyst performs immunofixation electrophoresis, typically on the patient’s serum, to diagnose and or monitor monoclonal gammopathies or myeloma, a bone marrow tumor. | 19,700 | $20 | $393.9K |
| 82378 | The lab analyst performs the technical lab test to analyze the quantity of carcinoembryonic antigen, or CEA, in the blood or other bodily fluid. Most commonly clinicians order a CEA test to monitor… | 19,670 | $20 | $373.8K |
| 88374 | The lab analyst applies a single multiplex in situ hybridization probe stain on a slide or slides prepared from a single patient specimen, such as tumor tissue. The lab analyst processes the slides… | 2,280 | $160 | $360.7K |
Showing 1–10 of 110
How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 110 CPT/HCPCS codes.
View: State1 / 2
Full comparison — all codes billed, vs. state median
110 rows
| CPT/HCPCS Code | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|
| 81455 | 4 | 10 | 80 | $2,860 | $2M |
| 88374 | 3 | 30 | 130 | $160 | $278.1K |
| 88185 | 5 | 20 | 4,720 | $20 | $222.5K |
| 81456 | 3 | 10 | 20 | $2,850 | $199.3K |
| 88237 | 3 | 10 | 140 | $140 | $175.8K |
| 83521 | 2 | 10 | 3,990 | $20 | $163.5K |
| 81279 | 15 | 30 | 140 | $180 | $106.7K |
| 88264 | 3 | 10 | 440 | $140 | $96.7K |
| 81206 | 5 | 10 | 110 | $160 | $87.7K |
| 88305 | 245 | 980 | 570 | $40 | $83.5K |
Showing 1–10 of 110
Medicaid revenue breakdown by year and by CPT/HCPCS procedure code, including monthly billing trends and the top codes driving revenue.
View: By Year1 / 3
Every CPT/HCPCS code this provider has billed to Medicaid, with claims volume, average payment, and total revenue.
1 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 80053 | The lab analyst performs a comprehensive metabolic panel, or CMP test in which he measures the blood level of 14 chemicals the code descriptor lists for the panel. | 60 | $1 | $60 |
How this provider's Medicaid billing volume and revenue compare to other Florida providers billing the same CPT/HCPCS codes.
Full comparison — all codes billed, vs. Florida median
1 rows
| CPT/HCPCS Code | Description | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|---|
| 80053 | The lab analyst performs a comprehensive metabolic panel, or CMP test in which he measures the blood level of 14 chemicals the code descriptor lists for the panel. | 567 | 640 | 4,400 | $10 | $193.4K |
Other providers in the same ZIP code as Ryan Olson, ranked by combined Medicare and Medicaid revenue.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.